Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hui You

Showing results (361-370 of 371) with videos related to

Pageof 38
Sort By:
BMC Neurology|June 14, 2024
The molecular signature and prognosis of glioma with preoperative intratumoral hemorrhage: a retrospective cohort analysisYixin Shi, Xiaoman Kang, Yulu Ge, et al.
Lancet (London, England)|December 4, 2014
Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2)Claudia Allemani, Hannah K Weir, Helena Carreira, et al.
Neuro-Oncology|March 19, 2021
The histology of brain tumors for 67 331 children and 671 085 adults diagnosed in 60 countries during 2000-2014: a global, population-based study (CONCORD-3)Fabio Girardi, Brian Rous, Charles A Stiller, et al.
Journal of Medicinal Chemistry|April 11, 2019
Discovery of Conformational Control Inhibitors Switching off the Activated c-KIT and Targeting a Broad Range of Clinically Relevant c-KIT MutantsTsung-Sheng Wu, Wen-Hsing Lin, Hui-Jen Tsai, et al.
The Lancet. Oncology|February 29, 2024
Use of chemotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based studySean McPhail, Matthew E Barclay, Shane A Johnson, et al.
Journal of Medicinal Chemistry|November 14, 2019
Identification of a Multitargeted Tyrosine Kinase Inhibitor for the Treatment of Gastrointestinal Stromal Tumors and Acute Myeloid LeukemiaWen-Hsing Lin, Su-Ying Wu, Teng-Kuang Yeh, et al.
Cancer Epidemiology|September 12, 2025
Chemotherapy use in ovarian cancer patients diagnosed 2012-2017 in Australia, Canada, Norway and the UK: An International Cancer Benchmarking Partnership (ICBP) population-based studyMatthew E Barclay, Sean McPhail, Shane A Johnson, et al.
The Lancet. Oncology|February 29, 2024
Use of radiotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based studySean McPhail, Matthew E Barclay, Ruth Swann, et al.
Journal of Alzheimer'S Disease : JAD|January 14, 2026
Prevalence of subjective cognitive decline with Alzheimer's disease neuropathology in a community-based Chinese cohortJing Yuan, Yaoda Hu, Feng Feng, et al.
Nature Communications|June 20, 2022
Multimodal deep learning for Alzheimer's disease dementia assessmentShangran Qiu, Matthew I Miller, Prajakta S Joshi, et al.
Pageof 38

Showing results (361-370 of 371) with videos related to

Sort By:
Pageof 38
BMC Neurology|June 14, 2024
The molecular signature and prognosis of glioma with preoperative intratumoral hemorrhage: a retrospective cohort analysisYixin Shi, Xiaoman Kang, Yulu Ge, et al.
Lancet (London, England)|December 4, 2014
Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2)Claudia Allemani, Hannah K Weir, Helena Carreira, et al.
Neuro-Oncology|March 19, 2021
The histology of brain tumors for 67 331 children and 671 085 adults diagnosed in 60 countries during 2000-2014: a global, population-based study (CONCORD-3)Fabio Girardi, Brian Rous, Charles A Stiller, et al.
Journal of Medicinal Chemistry|April 11, 2019
Discovery of Conformational Control Inhibitors Switching off the Activated c-KIT and Targeting a Broad Range of Clinically Relevant c-KIT MutantsTsung-Sheng Wu, Wen-Hsing Lin, Hui-Jen Tsai, et al.
The Lancet. Oncology|February 29, 2024
Use of chemotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based studySean McPhail, Matthew E Barclay, Shane A Johnson, et al.
Journal of Medicinal Chemistry|November 14, 2019
Identification of a Multitargeted Tyrosine Kinase Inhibitor for the Treatment of Gastrointestinal Stromal Tumors and Acute Myeloid LeukemiaWen-Hsing Lin, Su-Ying Wu, Teng-Kuang Yeh, et al.
Cancer Epidemiology|September 12, 2025
Chemotherapy use in ovarian cancer patients diagnosed 2012-2017 in Australia, Canada, Norway and the UK: An International Cancer Benchmarking Partnership (ICBP) population-based studyMatthew E Barclay, Sean McPhail, Shane A Johnson, et al.
The Lancet. Oncology|February 29, 2024
Use of radiotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based studySean McPhail, Matthew E Barclay, Ruth Swann, et al.
Journal of Alzheimer'S Disease : JAD|January 14, 2026
Prevalence of subjective cognitive decline with Alzheimer's disease neuropathology in a community-based Chinese cohortJing Yuan, Yaoda Hu, Feng Feng, et al.
Nature Communications|June 20, 2022
Multimodal deep learning for Alzheimer's disease dementia assessmentShangran Qiu, Matthew I Miller, Prajakta S Joshi, et al.
Pageof 38